ZA931221B - The use of hymenialdisine compounds for treating diseases requiring inhibition of protein Kinase C - Google Patents

The use of hymenialdisine compounds for treating diseases requiring inhibition of protein Kinase C

Info

Publication number
ZA931221B
ZA931221B ZA931221A ZA931221A ZA931221B ZA 931221 B ZA931221 B ZA 931221B ZA 931221 A ZA931221 A ZA 931221A ZA 931221 A ZA931221 A ZA 931221A ZA 931221 B ZA931221 B ZA 931221B
Authority
ZA
South Africa
Prior art keywords
hymenialdisine
compounds
protein kinase
treating diseases
diseases requiring
Prior art date
Application number
ZA931221A
Other languages
English (en)
Inventor
Ponnal Nambi
Ashok Dharmaji Patil
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ZA931221B publication Critical patent/ZA931221B/xx

Links

ZA931221A 1992-02-24 1993-02-22 The use of hymenialdisine compounds for treating diseases requiring inhibition of protein Kinase C ZA931221B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84035992A 1992-02-24 1992-02-24

Publications (1)

Publication Number Publication Date
ZA931221B true ZA931221B (en) 1993-11-29

Family

ID=25282154

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA931221A ZA931221B (en) 1992-02-24 1993-02-22 The use of hymenialdisine compounds for treating diseases requiring inhibition of protein Kinase C

Country Status (3)

Country Link
MX (1) MX9300957A (enrdf_load_stackoverflow)
TW (1) TW245639B (enrdf_load_stackoverflow)
ZA (1) ZA931221B (enrdf_load_stackoverflow)

Also Published As

Publication number Publication date
TW245639B (enrdf_load_stackoverflow) 1995-04-21
MX9300957A (es) 1994-08-31

Similar Documents

Publication Publication Date Title
AU2845492A (en) Dipyridamole for the treatment of proliferative diseases
HU9300536D0 (en) Compounds of medical effect
FI943805L (fi) Substituoituja adeniinijohdannaisten käyttö multippeliskleroosin hoitoon
AU1532492A (en) Use of heterocyclic compounds for the treatment of inflammatory pain
GB9226832D0 (en) Pharmaceutical preparations for the treatment of psoriasis
EP0510503A3 (en) Process for the treatment of surfaces
IL103205A0 (en) Compounds for treating leukotriene-related diseases
IL101410A0 (en) Formulation for the treatment of cancer
IL115320A0 (en) Retinoyloxy (substituted) methyl butyrates useful for the treatment of cancer and other proliferative diseases
IT1271567B (it) Procedimento per l'ulteriore trattamento di salcicce
GB2271579B (en) Treatment of wood
HU9401833D0 (en) Use of renin inhibitors for the treatment of glaucoma
IL104132A0 (en) Compositions for the treatment of mammalian diseases
AU4585993A (en) Use of angiotensin ii antagonists for the treatment of hyperlipidaeme
IL101317A0 (en) New compounds for use in the treatment of cancer
EP0457671A3 (en) Dipyridamide for the treatment of diseases of the central or peripheral nervous system
ZA931221B (en) The use of hymenialdisine compounds for treating diseases requiring inhibition of protein Kinase C
GB9219776D0 (en) New compounds for use in the treatment of cancer
NZ255753A (en) Use of substituted azaspiranes for psoriasis treatment
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
IL106064A0 (en) Gallium complexes for the treatment of free radicalinduced diseases
GB2312375B (en) Agents for treatment of cancer
AU4728893A (en) Use of macrolide compounds for the treatment of skin diseases
EP0460690A3 (en) Use of phenolsulfophthaline derivatives for the treatment of osteoporosis
AU5532094A (en) Therapeutic agents for the treatment of cachexia